Therapeutic Targets Database
BIDD Pharmainformatics Databases


TTD Drug ID: DAP000210

Drug Information
SynonymsLopid R; Fetinor; Sigma Brand of Gemfibrozil; Gemfibrozilum [INN-Latin]; BRN 1881200; Bexal Brand of Gemfibrozil; SPBio_002148; AC-4225; Micolip; HMS2090K14; Gemfibrozilo [INN-Spanish]; Nu-Gemfibrozil; Lanaterom; D015248; TAD Brand of Gemfibrozil; BSPBio_000227; gemfibrozil; Normolip; Hipolixan; Cantabria Brand of Gemfibrozil; 2,2-Dimethyl-5-(2,5-xylyloxy)valeriansaeure; Prestwick0_000214; KBio2_003873; Brozil; 5-(2,5-Dimethyl-Phenoxy)-2,2-Dimethyl-Pentanoic Acid; BRD-K11129031-001-05-1; WL-Gemfibrozil; Decrelip; Pfizer Brand of Gemfibrozil; Synbrozil; Prestwick2_000214; Bolutol; 5-[(2,5-dimethylphenyl)oxy]-2,2-dimethylpentanoic acid; CI719; Innogen; Gen-Fibro; BPBio1_000251; Lifibron; Quimifar Brand of Gemfibrozil; Gemfibromax; D00334; Fibratol; EINECS 247-280-2; Gen Gemfibrozil; Gemfibrozilo Bayvit; 2,2-Dimethyl-5-(2,5-xylyloxy)valeric acid; Warner-Lambert Brand of Gemfibrozil; Spectrum5_001991; Gen-Gemfibrozil; G9518_SIGMA; Fibrocit; Bayvit Brand of Gemfibrozil; SR-01000000056-6; Gemfibrozilo Bexal; AC1L1FZT; Genlip; Gozid; Gemfibrozilo; Gemfibrozil (JAN/USP/INN); KBio3_001280; Clearol; KBioGR_000964; Reducel; Lipozid; SR-01000000056; GenGemfibrozil; NCGC00016794-01; Lipizyl; Trialmin; Spectrum5_000750; Nu-Pharm Brand of Gemfibrozil; Nu Gemfibrozil; CI-719; Novopharm Brand of Gemfibrozil; Ipsen Brand of Gemfibrozil; UNII-Q8X02027X3; GEMFIBROZIL (SEE ALSO PEROXISOME PROJECT (GEMFIBROZIL)); STK618740; NCGC00022722-04; Renabrazin; Parke Davis Brand of Gemfibrozil; Apo-Gemfibrozil; Novo-Gemfibrozil; 1A Brand of Gemfibrozil; Healthsense Gemfibrozil; Spectrum_000825; Chem mart Gemfibrozil; Innogem; BB_SC-4837; Terry White Chemists Brand of Gemfibrozil; LS-1085; Bull Brand of Gemfibrozil; IDI1_000138; CPD000058393; Lipazil; Jezil; Prestwick_637; Lipigem; Menarini Brand of Gemfibrozil; Healthsense Brand of Gemfibrozil; Hidil; DivK1c_000138; Ipolipid; Gemfi 1A Pharma; Pilder; MLS001055364; I01-1855; AC1Q2JC7; nchembio790-comp22; ApoGemfibrozil; SPBio_001174; Spectrum2_001097; Cholespid; Gemfibril; Polyxit; Alphapharm Brand of Gemfibrozil; NCGC00016794-02; KBioSS_001305; Farmasierra Brand of Gemfibrozil; S1729_Selleck; TL8002081; PMS-Gemfibrozil; Sinelip; NCGC00022722-05; Progemzal; Low-Lip; CHEMBL457; Prestwick3_000214; Gemd; United Drug Brand of Gemfibrozil; Ausgem; Genpharm Brand of Gemfibrozil; NINDS_000138; Gevilon Uno; Spectrum4_000562; Tentroc; Lipira; 2,2-Dimethyl-5-(2,5-dimethylphenoxy)pentanoic acid; HMS1568L09; Taborcil; Lipur; Apo Gemfibrozil; SBPA Gemfibrozil; AB00052003; SPECTRUM1500313; Pharmascience Brand of Gemfibrozil; AKOS001606691; NCGC00022722-06; Chem mart Brand of Gemfibrozil; Litarek; DBL Gemfibrozil; Biochemie Brand of Gemfibrozil; CID3463; SAM002564211; Elmogan; Gemlipid; CAS-25812-30-0; Apotex Brand of Gemfibrozil; Nu Pharm Brand of Gemfibrozil; GenRX Gemfibrozil; MLS000028421; SMR000058393; NCGC00022722-03; NuGemfibrozil; Gemfibrozil [USAN:BAN:INN]; Novo Gemfibrozil; Regulip; Terry White Chemists Gemfibrozil; Valeric acid, 2,2-dimethyl-5-(2,5-xylyloxy)-; Gemfibrozil, GenRX; PMS Gemfibrozil; Pentanoic acid, 5-(2,5-dimethylphenoxy)-2,2-dimethyl-; HMS1920B07; 2,2-Dimethyl-5-(2,5-dimethylphenoxy)valeriansaeure; BSPBio_002060; Lipox Gemfi; CHEBI:5296; Spectrum3_000440; 5-(2,5-Dimethylphenoxy)-2,2-dimethylpentanoic acid; MolPort-001-794-413; GFZ; Bayvit, Gemfibrozilo; Lopid; Douglas Brand of Gemfibrozil; PEROXISOME PROJECT (GEMFIBROZIL) (SEE ALSO GEMFIBROZIL); Gemnpid; CCRIS 318; TEVA-A; Gemfibrozil, SBPA; 25812-30-0; KBio2_006441; Faulding Brand of Gemfibrozil; Gemcor, Lopid, Jezil, Gen-Fibro, Gemfibrozil; KBio1_000138; NCGC00022722-07; Warner Lambert Brand of Gemfibrozil; Gemfibrozilum; Gem-S; HMS2091H11; Hexal Brand of Gemfibrozil; Gemfibrozilo Ur; Ferrer Brand of Gemfibrozil; HMS500G20; Gemfibrozil, Healthsense; Prestwick1_000214; Gemfibrosil; KBio2_001305; DB01241; Lopid (TN); CI 719; Gemhexal; ARONIS24091    
Trade NameLopid; Jezil; Gen-Fibro    
CompanyPfizer Pharmaceuticals    
IndicationHyperlipidemiaApproved    [1]

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
Therapeutic ClassAntilipemic Agents    
CAS NumberCAS 25812-30-0
PubChem Compound IDCID 3463.    
PubChem Substance IDSID 175056.    
SuperDrug ATC IDC10AB04;    
SuperDrug CAS ID025812300;    
TargetLipoprotein lipaseActivator[2]
Ref 1FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (ANDA) 074256 To Reference
Ref 2Mode of action of fibrates in the regulation of triglyceride and HDL-cholesterol metabolism. Drugs Today (Barc). 2006 Jan;42(1):39-64. To Reference


Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.

Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543